Depression Flashcards
CNS Neurotransmitters
Acetylcholine Gamma-aminobutyric acid Dopamine Glutamate Norepinephrine
PNS Neurotransmitters
Acetylcholine
Norepinephrine
Sympathetic System
Acetylcholine
Dopamine
Epinephrine
Norepinephrine
PNS Neurotransmitters
Acetylcholine
Depression Prevalence
Affects up to 19 million Americans
-31 million adults report having had at least one episode of major depression in their lifetime
Annual costs of $43 billion equal to the annual health care costs for coronary heart disease
Can affect all age groups
- Women 2 to 3 times more likely to develop depression than men - If left untreated, 15% of adult patients will commit suicide
Diagnosis of Depression
Depressed mood or loss of interest/pleasure in activities for at least two weeks
plus
At least four of the following seven factors in the same two week period
- Change in sleep pattern
- Change in appetite/weight
- Fatigue
- Psychomotor agitation or retardation
- Feelings of worthlessness/guilt
- Difficulty thinking, concentrating or indecisiveness
- Recurrent thoughts of death, suicidal ideation, plans, attempts
Premenstrual Dysphoric Disorder Diagnosis
Five or more of the following occuring during the final week before the onset of menses: Marked affective lability Markedly depressed mood Decreased interest Lethargy Sleep pattern change Marked irritability Marked anxiety Difficulty concentrating Change in appetite Physical symptoms
Monoamine Oxidase Inhibitors
Tranylcypromine
Isocarboxazid
Phenelzine
Selegeline
Childhood Bipolar Disorder is now
Disruptive Mood Dysregulation Disorder
New Depression diagnoses in DSM-V
Disruptive Mood Dysregulation Disorder
Premenstrual Dysphoric Disorder
Tricyclic Depressants
Secondary Amines
Tertiary Amines
Tertracyclic Amine
Tetracyclic Amine
Maprotiline
Tertiary Amines
Amitriptyline Clomipramine Doxepin Imipramine Trimipramine
Selegeline mechanism of administration
Topical patch
Secondary Amines
Nortriptyline
Desipramine
MOA MOIs
Effects the enzyme monoamine oxidase so the body loses its ability to breakdown monoamines which increases the levels of NE in the body.
Nobody uses
MOIs
Indications for Phenelzine
Symptomatic treatment of atypical, nonendogenous, or neurotic depression
Dosage forms of Phenelzine
Tablet
Dosing of Phenelzine
Oncea day or every 2 days
Selegeline indications
Treatment of major depressive disorder.
Dosage form of Selegeline
Topical Patch
Dosing of Selegeline
Once a Day
Black Box Warning of MOIs
Suicidal Thinking/ Behavior
-Age groupings